<!DOCTYPE html>
<html><head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Your site description">
    
    <link rel="shortcut icon" href="https://emily.systems/favicon.ico">
    
    <link rel="stylesheet" href="/css/style.min.css">

    <title>deleuzian chemicals</title>
</head>
<body><header id="banner">
    <h2><a href="https://emily.systems">emily.systems</a></h2>
    <nav>
        <ul>
            <li>
                <a href="/about/" title="about">about</a>
            </li>
        </ul>
    </nav>
</header>
<main id="content">
<article>
    <header id="post-header">
        <h1>deleuzian chemicals</h1>
        <div>
                <time>June 16, 2020</time>
            </div>
    </header><h3 id="introduction">Introduction</h3>
<p>In 1972, Deleuze &amp; Guattari published <em>Anti-Oedipus</em>, where they attempted to ground psychoanalysis in material conditions to show the historical contingency of the Freudian unconscious.</p>
<blockquote>
<p>&ldquo;<em>Our society produces schizos the same way it produces Prell shampoo or Ford cars</em>&rdquo; (245)</p>
</blockquote>
<p>D&amp;G explain that capitalism produces schizophrenics but must suppress them as &ldquo;<em>desire is revolutionary in its essence</em>&rdquo; (118). While reading, I found many parallels with their transcendental unconscious and neurotransmitter receptors, especially how they each relate to schizophrenia. This is jargon-heavy, and I don&rsquo;t have academic training in neuroscience OR Deleuze, but hopefully the connections I found is understandable.</p>
<p>In short, D&amp;G&rsquo;s schizoanalytic ontology is based on assemblages of &ldquo;desiring-machines&rdquo;. Machines create connections to produce flows of <a href="https://en.wikipedia.org/wiki/Lack_(manque)">non-lacking desire</a>. The unconscious follows three syntheses:</p>
<h3 id="the-connective-synthesis-as-d1-receptorhttpsenwikipediaorgwikidopamine_receptor_d1">The connective synthesis as <a href="https://en.wikipedia.org/wiki/Dopamine_receptor_D1">D1 receptor</a></h3>
<blockquote>
<p>&ldquo;<em>every machine is a machine connected to another machine.</em>&rdquo; (8)</p>
</blockquote>
<p>The connective synthesis of production is desiring-machines connecting with one another. D&amp;G speak of it as a series of &ldquo;<em>and&hellip;and then&hellip;and then&hellip;</em>&rdquo; (5). I understand this synthesis to be similar to the affects of the D1 receptor, specifically the idea of dopamine acting as a reward system<sup id="fnref:1"><a href="#fn:1" class="footnote-ref" role="doc-noteref">1</a></sup> increasing motivation for repetition. The connective synthesis risks falling into fixation, something that the addictive potential of dopamine<sup id="fnref:2"><a href="#fn:2" class="footnote-ref" role="doc-noteref">2</a></sup> does as well. For example, dopamine can invoke pathological behaviors involving repetition<sup id="fnref:3"><a href="#fn:3" class="footnote-ref" role="doc-noteref">3</a></sup> and compulsiveness<sup id="fnref:4"><a href="#fn:4" class="footnote-ref" role="doc-noteref">4</a></sup> which align with D&amp;G&rsquo;s connective synthesis.</p>
<p>Eugene W. Holland writes:</p>
<blockquote>
<p>&ldquo;<em>At one extreme &ndash; connection without disjunction &ndash; you would have total fixation on an instinctually or habitually predetermined object [..] at the other &ndash; disjunection without connection &ndash; you would have total withdrawl from contact with reality</em>&rdquo; (The Cambridge Companion to Deleuze, 323)</p>
</blockquote>
<h3 id="the-disjunctive-synthesis-as-d2-receptorhttpsenwikipediaorgwikidopamine_receptor_d2">The disjunctive synthesis as <a href="https://en.wikipedia.org/wiki/Dopamine_receptor_D2">D2 receptor</a></h3>
<blockquote>
<p>&ldquo;<em>Freud stresses the importance of these disjunctive syntheses in Schreber&rsquo;s
delirium in particular, but also in delirium as a general phenomenon.</em>&rdquo; (13)</p>
</blockquote>
<p>I will only write a portion of the disjunective synthesis as much of it is out of scope for this context. We can say it deals with the interruption of connections, which in turn allows for new connections. The D2 receptor is very similar; it also is associated with the novel<sup id="fnref:5"><a href="#fn:5" class="footnote-ref" role="doc-noteref">5</a></sup> rather than the continuation of the same. This is why D&amp;G associate it with the series of &ldquo;<em>&hellip;either&hellip;or&hellip;or&hellip;</em>&rdquo; (70). This reminds me of the symptoms of ADHD, such as the inability to focus at length<sup id="fnref:6"><a href="#fn:6" class="footnote-ref" role="doc-noteref">6</a></sup>. ADHD could be viewed as a subject being unable to hold onto connections, and one possible cause of ADHD is increased D2 activity<sup id="fnref:7"><a href="#fn:7" class="footnote-ref" role="doc-noteref">7</a></sup>.</p>
<p>In the same way the risk of the disjunctive synthesis is schizophrenia (according to D&amp;G, as a clinical entity), the D2 receptor is one of the major hypotheses of schizophrenia<sup id="fnref:8"><a href="#fn:8" class="footnote-ref" role="doc-noteref">8</a></sup>. Many anti-psychotics act as antagonists for the D2 receptor<sup id="fnref:9"><a href="#fn:9" class="footnote-ref" role="doc-noteref">9</a></sup>, as well as many psychotomimetic drugs like Salvinorin and LSD act as (partial) agonists<sup id="fnref:10"><a href="#fn:10" class="footnote-ref" role="doc-noteref">10</a></sup>. The D2 receptor and the disjunctive synthesis are similar as they both break up repetitive behaviors and fixations, produce novel connections, and have the risk of breakdown.</p>
<h3 id="the-conjunctive-synthesis-as-nmdarhttpsenwikipediaorgwikinmda_receptor">The conjunctive synthesis as <a href="https://en.wikipedia.org/wiki/NMDA_receptor">NMDAr</a></h3>
<p>The conjunctive synthesis of consumption is what produces subjectivity. This subjectivity arises from the &ldquo;consumption&rdquo; of intensities caused from prior syntheses:</p>
<blockquote>
<p>&ldquo;<em>Where do these pure intensities come from? They come from the two preceding forces, repulsion and attraction</em>&rdquo; (19)</p>
</blockquote>
<p>He states that at zero-intensity is a catatonic body:</p>
<blockquote>
<p>&ldquo;<em>it is catatonic schizophrenia that gives its model to death. Zero intensity</em>&rdquo; (329)</p>
</blockquote>
<p>Therefore, subjectivity is the opposite of zero intensity/catatonia. One way we can approach zero intensity is through <a href="https://en.wikipedia.org/wiki/NMDA_receptor_antagonist">NMDAr antagonists</a> which can produce a loss of consciousness<sup id="fnref:11"><a href="#fn:11" class="footnote-ref" role="doc-noteref">11</a></sup>. Schizophrenia as a clinical entity (often catatonic, as D&amp;G mention) is hypothesized as low NMDA activity<sup id="fnref:12"><a href="#fn:12" class="footnote-ref" role="doc-noteref">12</a></sup>. This means that the production of subjectivity could be associated with the activity of the NMDA receptor. A higher intensity or subjectivity could be associated with increasing NMDA activity, something psychedelics have the ability to do<sup id="fnref:13"><a href="#fn:13" class="footnote-ref" role="doc-noteref">13</a></sup>.</p>
<p>This image can show what intensive subjectivity may mean. Giving a normal brain (left) a 5-HT2a agonist causes glutamate to release<sup id="fnref:14"><a href="#fn:14" class="footnote-ref" role="doc-noteref">14</a></sup>, increasing NMDA receptor activity<sup id="fnref:15"><a href="#fn:15" class="footnote-ref" role="doc-noteref">15</a></sup> and thus increasing &ldquo;subjectivity&rdquo;. This gives us a picture of what increased subjectivity <em>may</em> look like (right) according to Deleuze and Guattari.</p>
<p><img src="http://u.cubeupload.com/n23/transparent.png" alt="DMN psychedelic"></p>
<p>*[D&amp;G]: Deleuze and Guattari</p>
<section class="footnotes" role="doc-endnotes">
<hr>
<ol>
<li id="fn:1" role="doc-endnote">
<p><a href="https://doi.org/10.1016/j.coph.2006.11.003">https://doi.org/10.1016/j.coph.2006.11.003</a> <a href="#fnref:1" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:2" role="doc-endnote">
<p><a href="https://pubmed.ncbi.nlm.nih.gov/31905114/">https://pubmed.ncbi.nlm.nih.gov/31905114/</a> <a href="#fnref:2" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:3" role="doc-endnote">
<p><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858339/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858339/</a> <a href="#fnref:3" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:4" role="doc-endnote">
<p><a href="https://pubmed.ncbi.nlm.nih.gov/20136383/">https://pubmed.ncbi.nlm.nih.gov/20136383/</a> <a href="#fnref:4" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:5" role="doc-endnote">
<p><a href="https://pubmed.ncbi.nlm.nih.gov/11304084/">https://pubmed.ncbi.nlm.nih.gov/11304084/</a> <a href="#fnref:5" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:6" role="doc-endnote">
<p>One could easily make sense of more symptoms as &lsquo;breaking connections&rsquo;; more <a href="https://www.cdc.gov/ncbddd/adhd/diagnosis.html">here</a> <a href="#fnref:6" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:7" role="doc-endnote">
<p><a href="https://pubmed.ncbi.nlm.nih.gov/11730150/">https://pubmed.ncbi.nlm.nih.gov/11730150/</a> <a href="#fnref:7" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:8" role="doc-endnote">
<p><a href="https://en.wikipedia.org/wiki/Dopamine_hypothesis_of_schizophrenia">https://en.wikipedia.org/wiki/Dopamine_hypothesis_of_schizophrenia</a> <a href="#fnref:8" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:9" role="doc-endnote">
<p><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112764/#__sec4title">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112764/#__sec4title</a> <a href="#fnref:9" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:10" role="doc-endnote">
<p><a href="https://en.wikipedia.org/wiki/Dopamine_receptor_D2#Partial_agonists">https://en.wikipedia.org/wiki/Dopamine_receptor_D2#Partial_agonists</a> <a href="#fnref:10" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:11" role="doc-endnote">
<p><a href="https://pubmed.ncbi.nlm.nih.gov/22291389/">https://pubmed.ncbi.nlm.nih.gov/22291389/</a> <a href="#fnref:11" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:12" role="doc-endnote">
<p><a href="https://en.wikipedia.org/wiki/Glutamate_hypothesis_of_schizophrenia">https://en.wikipedia.org/wiki/Glutamate_hypothesis_of_schizophrenia</a> <a href="#fnref:12" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:13" role="doc-endnote">
<p><a href="https://www.sciencedirect.com/science/article/abs/pii/S0006899304011813">https://www.sciencedirect.com/science/article/abs/pii/S0006899304011813</a> <a href="#fnref:13" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:14" role="doc-endnote">
<p><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743172/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743172/</a> <a href="#fnref:14" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:15" role="doc-endnote">
<p><a href="https://en.wikipedia.org/wiki/NMDA_receptor#Gating">https://en.wikipedia.org/wiki/NMDA_receptor#Gating</a> <a href="#fnref:15" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
</ol>
</section>
</article>

        </main><footer id="footer">
    
</footer>
</body>
</html>
